UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000006999
Receipt number	R000008261
Scientific Title	Phase II randomized trail of Gemcitabine and Irinotecan in Patients with Platinum Refractory and Resistant Mullerian carcinoma (tailored dose vs optimal dose chemotherapy)
Date of disclosure of the study information	2012/01/01
Last modified on	2012/01/01 11:00:00

---